Ipsita Panda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ipsita Panda has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
A. Sekharan
Asian Institute of Gastroenterology, Pathology, Hyderabad, India
1 shared publication- Abhirup Chatterjee
Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication - Anindita Das
Pathology and Clinical Governance Australian Red Cross Lifeblood Melbourne Victoria Australia
1 shared publication - Arup Choudhury
Gastroenterology Unit, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
1 shared publication D.N. Reddy
Asian Institute of Gastroenterology, Gastroenterology, Hyderabad, India
1 shared publicationG. Muktesh
Postgraduate Institute of Medical and Research, Gastroenterology, Chandigarh, India
1 shared publication
Latest Publications
- 8 November 2025
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 26 (4) , 449-451
EBV-related diffuse large B cell lymphoma in ulcerative colitis after brief thiopurine exposure
- 8 November 2025
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 26 (4) , 449-451
EBV-related diffuse large B cell lymphoma in ulcerative colitis after brief thiopurine exposure
- 14 April 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 01) , S96-S97
EUS-GUIDED LIVER BIOPSY SCORES OVER RADIOLOGY GUIDED PERCUTANEOUS LIVER BIOPSY: A MULTICENTER RANDOMISED CONTROLLED TRIAL
Aims Liver biopsy can be performed by the traditional percutaneous radiology guided route (PC-LB) or under endoscopic ultrasound guidance (EUS-LB) and limited data exist on the comparison between the two and hence this study was planned. Methods This is a parallel-group, single-blinded, randomized controlled trial conducted at two tertiary care centers in India from July 2020-August 2021. Consecutive patients requiring liver biopsy were randomized into either the EUS-LB or the PC-LB arm. Aggregate specimen length, longest specimen length, number of complete portal tracts (CPTs), and diagnostic adequacy were assessed. Post-procedure pain was measured using the visual analog scale (VAS) at 1, 4, and 24 hrs post-procedure. Results A total of 48 patients (30 males; 62.5% with a mean age of 37.25±12.7 years) were randomized into EUS-LB (n=24) and PC-LB (n=24). EUS-LB yielded significantly greater aggregate specimen length (33.5 vs 15.0 mm; p<0.0001) and a higher number of CPTs (17.5 vs. 7.5; p<0.001). The longest length of the specimen was noted in PC-LB arm (10.5 vs. 8.0;p=0.04). Diagnostic adequacy was similar between the two arms. The most common post-procedure side effect was pain. Pain was noted in higher proportion in PC-LB arm (87.5% vs. 16.7%; p<0.001) and had higher analgesic requirement (41.7% vs 4.2%;p=0.004). VAS score was significantly higher in the PC-LB at all the measured time points of 1, 4, and 24 hrs (p<0.001). Conclusions EUS-LB showed significantly better aggregate specimen length and more CPTs compared to PC-LB. Post-procedure pain in the first 24 hrs was significantly greater in the PC-LB arm.(Trial No:CTRI/2020/09/027989) Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 01) , S96-S97
EUS-GUIDED LIVER BIOPSY SCORES OVER RADIOLOGY GUIDED PERCUTANEOUS LIVER BIOPSY: A MULTICENTER RANDOMISED CONTROLLED TRIAL
Aims Liver biopsy can be performed by the traditional percutaneous radiology guided route (PC-LB) or under endoscopic ultrasound guidance (EUS-LB) and limited data exist on the comparison between the two and hence this study was planned. Methods This is a parallel-group, single-blinded, randomized controlled trial conducted at two tertiary care centers in India from July 2020-August 2021. Consecutive patients requiring liver biopsy were randomized into either the EUS-LB or the PC-LB arm. Aggregate specimen length, longest specimen length, number of complete portal tracts (CPTs), and diagnostic adequacy were assessed. Post-procedure pain was measured using the visual analog scale (VAS) at 1, 4, and 24 hrs post-procedure. Results A total of 48 patients (30 males; 62.5% with a mean age of 37.25±12.7 years) were randomized into EUS-LB (n=24) and PC-LB (n=24). EUS-LB yielded significantly greater aggregate specimen length (33.5 vs 15.0 mm; p<0.0001) and a higher number of CPTs (17.5 vs. 7.5; p<0.001). The longest length of the specimen was noted in PC-LB arm (10.5 vs. 8.0;p=0.04). Diagnostic adequacy was similar between the two arms. The most common post-procedure side effect was pain. Pain was noted in higher proportion in PC-LB arm (87.5% vs. 16.7%; p<0.001) and had higher analgesic requirement (41.7% vs 4.2%;p=0.004). VAS score was significantly higher in the PC-LB at all the measured time points of 1, 4, and 24 hrs (p<0.001). Conclusions EUS-LB showed significantly better aggregate specimen length and more CPTs compared to PC-LB. Post-procedure pain in the first 24 hrs was significantly greater in the PC-LB arm.(Trial No:CTRI/2020/09/027989) Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany